Rare diseases
Investigational molecules
Locations
Back to Italy3 clinical trials in Olbia, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)ItalyItalyItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on Type 2 Diabetes Mellitus management, comparing the effectiveness of novel treatments like tirzepatide with established therapies. Studies aim to evaluate cardiovascular outcomes and long-term glycemic control.
Research emphasizes both immediate metabolic control and long-term health outcomes.
Groundbreaking research examining the combined effects of treatments for patients with chronic kidney disease and diabetes. Studies evaluate innovative therapeutic combinations targeting kidney function markers.
Focus on developing more effective treatment strategies for complex comorbid conditions.
Pioneering research into rare inflammatory conditions, specifically studying PAPA syndrome treatment approaches. Investigations focus on understanding the role of IL-1 blockade in managing inflammatory responses.
Advancing understanding of complex inflammatory conditions through targeted therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
